Report cover image

Clinical Trials - The Expanding Landscape of Regenerative Medicine

Publisher GlobalData
Published Nov 30, 2022
Length 30 Pages
SKU # GBDT17567990

Description

Clinical Trials - The Expanding Landscape of Regenerative Medicine

Summary

This report provides an overview of global regenerative medicine clinical trials and an analysis of any trends through the years.

Scope
  • The clinical trials data used for these analyses were extracted from GlobalData’s Clinical Trials Database. The data was captured in the database as of September 8, 2022. The data has been analyzed by trial start year, phase, status, sponsor type, geography, single-country vs. multinational, virtual components, therapy area, indication, reasons for discontinuation, endpoint status, sponsors, and drugs.
Reasons to Buy
  • Trends of regenerative medicine trials through the years
  • Comparison of trials by sponsor type
  • Can view top therapy areas, indications, geographies and sponsors
  • Focus on the usage of decentralized clinical trials/virtual components
  • Analysis of top drugs used

Table of Contents

30 Pages
Executive Summary
Introduction
The Expanding Landscape of Regenerative Medicine
2020 Has the Most Regenerative Medicine Clinical Trials
Phase II Trials Top Regenerative Medicine Trials
Industry-Sponsored Trials Dominate
North America and the US Saw the Most Trials
North America Has the Most Single-Country Trials While Europe Has the Most Multinational
Virtual Components Used Less in Regenerative Medicine Clinical Trials
Cardiovascular Is the Most Researched Therapy Area
Low Accrual Rate Is the Leading Cause of Trial Termination
Phase II and Industry-Sponsored Trials Achieved Their Endpoints More Frequently
Mesoblast Is the Top Industry Sponsor
Foundation for Orthopedics and Regenerative Medicine Is the Top Non-industry Sponsor
Tisagenlecleucel Is the Top Drug Used in Regenerative Medicine Clinical Trials
Key Findings
Appendix
List of Figures
Figure 1: Number of regenerative medicine clinical trials, by trial start year
Figure 2: Regenerative medicine clinical trials, by phase and status
Figure 3: Number of regenerative medicine clinical trials, by sponsor type and year
Figures
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.